PP405 has released results of phase 2a of trials

https://www.hairlosscure2020.com/pelage-pharmaceuticals-clinical-trials/

>Note that the trial participants just had 4 weeks of treatment. At another 4 weeks after the completion of this treatment (“in men with a higher degree of hair loss”), 31% of those treated with PP405 exhibited a greater than 20% increase in hair density.

>Notably, PP405 stimulated new hair growth from previously inactive follicles, highlighting its unique regenerative capabilities.

Phase 3 is expected for 2026, this timeline suggests a release date of 2028-2030